LIDOCAINE
- Manufacturer
- SUNFLORA, INC
- Effective date
- 2022-05-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 9
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:00:35
Label at a glance#
ProductLIDOCAINE
Active ingredientLIDOCAINE
Label structure1 sections
Label contents#
Full prescribing information#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73240-004-03 | 2024-11-21 | C162847 | 48780-1 | 1030e365-577d-111a-e063-dadaa90a10e2 | 73240-004-03 |
| 73240-004-03 | 2024-01-30 | C162847 | 48780-1 | 1030e365-577d-111a-e063-dadaa90a10e2 | 73240-004-03 |
Products#
Every source-derived product name is available through these pages.
- LIDOCAINE
- BUTYLENE GLYCOL
- HEXYLENE GLYCOL
- WATER
- GLYCERYL STEARATE SE
- CAPRYLYL GLYCOL
- DIMETHICONE 1000
- XANTHAN GUM
- GLYCERIN
- PHENOXYETHANOL
- CANNABIS SATIVA SEED OIL
- ARNICA MONTANA FLOWER WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 73240-004 | 73240-004-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| HEXYLENE GLYCOL | KEH0A3F75J | IACT |
| WATER | 059QF0KO0R | IACT |
| GLYCERYL STEARATE SE | FCZ5MH785I | IACT |
| CAPRYLYL GLYCOL | 00YIU5438U | IACT |
| DIMETHICONE 1000 | MCU2324216 | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| CANNABIS SATIVA SEED OIL | 69VJ1LPN1S | IACT |
| ARNICA MONTANA FLOWER WATER | U7L2JP51PR | IACT |
| LIDOCAINE | 98PI200987 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 275e1aed-7991-7f26-e063-6394a90aa0f2 | b9cfcc8d-c3f4-d253-e053-2a95a90a31b3 | 2024-11-20 | b9cfcc8d-c3f4-d253-e053-2a95a90a31b3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
